Duhring–Brocq disease

Duhring–Brocq disease, also known as Dermatitis Herpetiformis (DH), is a chronic skin condition characterized by blistering, intensely itchy skin. The disease is named after Louis Adolphus Duhring and Ernest Henri Besnier (Brocq was a pseudonym used by Besnier), who were the first to describe the condition in the late 19th century. DH is closely associated with celiac disease, a gluten-sensitive enteropathy, and is considered to be a cutaneous manifestation of celiac disease.

Symptoms and Signs

The primary symptom of Duhring–Brocq disease is an intense burning, itching, and stinging sensation in the affected areas. This is followed by the appearance of small blisters, primarily on the elbows, knees, back, buttocks, and scalp. The blisters are symmetrically distributed and filled with a clear fluid. Scratching leads to open sores, which can become infected. Despite being a skin condition, some individuals with DH may also experience symptoms related to celiac disease, such as diarrhea, abdominal pain, and malabsorption.

Causes

Duhring–Brocq disease is primarily caused by a sensitivity to gluten, a protein found in wheat, barley, and rye. In individuals with DH, ingestion of gluten leads to an autoimmune response that deposits IgA antibodies in the skin, resulting in the characteristic blisters and itching. The exact mechanism by which gluten consumption leads to skin lesions is not fully understood, but it is known that the majority of individuals with DH have the genetic markers HLA-DQ2 or HLA-DQ8, which are also associated with celiac disease.

Diagnosis

Diagnosis of Duhring–Brocq disease involves a physical examination, patient history, and several tests. A skin biopsy is performed to examine the affected skin under a microscope, and direct immunofluorescence testing of the biopsy samples can detect the presence of IgA deposits in the skin, confirming the diagnosis. Blood tests may also be conducted to check for the presence of specific antibodies associated with celiac disease.

Treatment

The primary treatment for Duhring–Brocq disease is a strict gluten-free diet, which can help to alleviate both the dermatological and gastrointestinal symptoms associated with the condition. Dapsone, an antibiotic, is often prescribed to provide immediate relief from itching and blistering. However, dapsone does not treat the underlying cause of the disease, and a gluten-free diet is necessary to manage the condition long-term. Other medications, such as corticosteroids, may be used to reduce inflammation in severe cases.

Prognosis

With adherence to a gluten-free diet, the prognosis for individuals with Duhring–Brocq disease is generally good. Most patients experience a significant reduction in skin lesions and itching. However, because DH is a chronic condition, symptoms may recur if gluten is reintroduced into the diet.

Epidemiology

Duhring–Brocq disease is relatively rare, affecting both men and women, usually appearing for the first time between the ages of 15 and 40. However, it can occur at any age. The condition is more common in individuals of Northern European descent and those with a personal or family history of celiac disease or other autoimmune disorders.

Duhring–Brocq disease Resources
Latest articles Most recent articles Ongoing trials	Wikipedia